{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T18:52:19Z","timestamp":1761763939718,"version":"build-2065373602"},"reference-count":31,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2003,1,7]],"date-time":"2003-01-07T00:00:00Z","timestamp":1041897600000},"content-version":"vor","delay-in-days":6,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bjui-journals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJU International"],"published-print":{"date-parts":[[2003,1]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>To examine cyclooxygenase (COX)\u20102 expression (a key enzyme in the synthesis of prostaglandins, and involved in carcinogenesis of human epithelial tumours) in human transitional cell carcinomas (TCCs) of the renal pelvis and ureter, and to determine whether COX\u20102 expression correlates with the clinicopathological characteristics of the disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MATERIALS AND METHODS<\/jats:title>\n                    <jats:p>Specimens from 144 patients with TCC of the upper urinary tract who had undergone nephroureterectomy were analysed immunohistochemically, and 23 were also analysed by immunoblotting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>\n                      Immunoblot analysis showed COX\u20102 immunoreactivity in 17 (74%) of 23 tumours, but not in normal transitional epithelium. COX\u20102 was localized to the cytoplasm of cancer cells and expressed in 108 (75%) of 144 tumours, as assessed by immunohistochemical analysis. COX\u20102 expression correlated with tumour grade (\n                      <jats:italic>P<\/jats:italic>\n                      \u2003&lt;\u20030.008), being detected in one of nine grade 1, 77 (79%) of 97 grade 2 and 30 (79%) of 38 grade 3 tumours. Other variables including tumour stage were not associated with COX\u20102 expression.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>We show for the first time that COX\u20102 is frequently expressed in TCC of the upper urinary tract and is associated with the degree of tumour cell differentiation, indicating that COX\u20102 may be involved in TCC carcinogenesis at an early and\/or late stage, and could be a useful target for chemoprevention of this type of cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1046\/j.1464-410x.2003.03057.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T03:13:00Z","timestamp":1047352380000},"page":"109-114","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Overexpression of cyclooxygenase\u20102 in high\u2010grade human transitional cell carcinoma of the upper urinary tract"],"prefix":"10.1111","volume":"91","author":[{"given":"S.","family":"Oku","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Higashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Imazono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Sueyoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Enokida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Yonezawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Shirahama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2003,1,7]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(97)99999-6"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-216-44170"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.274.5286.430"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81988-1"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI9621"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(97)70007-6"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(95)90127-2"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81433-6"},{"key":"e_1_2_6_10_2","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1038\/70995","article-title":"Inhibition of angiogenesis by nonsteroidal anti\u2010inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing","volume":"12","author":"Jones MK","year":"1999","journal-title":"Nature Med"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.7.3336"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200006293422603"},{"key":"e_1_2_6_13_2","first-page":"2424","article-title":"Cyclooxygenase\u20102 expression is up\u2010regulated in transitional cell carcinoma and its preneoplastic lesions in the human urinary bladder","volume":"6","author":"Shirahama T","year":"2000","journal-title":"Clin Cancer Res"},{"key":"e_1_2_6_14_2","first-page":"558","article-title":"Overexpression of cyclooxygenase\u20102 in squamous cell carcinoma of the urinary bladder","volume":"7","author":"Shirahama T","year":"2001","journal-title":"Clin Cancer Res"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19870301)59:5<972::AID-CNCR2820590520>3.0.CO;2-Y"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(99)70136-8"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365598309179795"},{"volume-title":"General Rules for Clinical and Pathological Studies on Renal Pelvic and Ureteral Cancer","year":"1990","author":"The Japanese Urological Association and the Japanese Society of Pathology","key":"e_1_2_6_18_2"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(76)90527-3"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(96)00244-4"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64513-0"},{"key":"e_1_2_6_22_2","first-page":"2383","volume-title":"Campbell's Urology","author":"Edward MM","year":"1998"},{"key":"e_1_2_6_23_2","first-page":"3785","article-title":"Expression of cyclooxygenase\u20101 and \u20102 in human colorectal cancer","volume":"55","author":"Sano H","year":"1995","journal-title":"Cancer Res"},{"key":"e_1_2_6_24_2","first-page":"4997","article-title":"Expression of cyclooxygenase\u20102 in human lung carcinoma","volume":"58","author":"Wolff H","year":"1998","journal-title":"Cancer Res"},{"key":"e_1_2_6_25_2","first-page":"987","article-title":"Cyclooxygenase\u20102 expression is up\u2010regulated in human pancreatic cancer","volume":"59","author":"Tucker ON","year":"1999","journal-title":"Cancer Res"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199305063281805"},{"key":"e_1_2_6_27_2","first-page":"5647","article-title":"Expression of cyclooxygenase\u20102 (COX\u20102) in human invasive transitional cell carcinoma (TCC) of the urinary bladder","volume":"59","author":"Mohammed SI","year":"1999","journal-title":"Cancer Res"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1998.197"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20010701)92:1<188::AID-CNCR1308>3.0.CO;2-W"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.282.13.1254"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.16.10911"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/25.1.151"}],"container-title":["BJU International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1464-410X.2003.03057.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1464-410X.2003.03057.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T17:00:03Z","timestamp":1761757203000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/10.1046\/j.1464-410X.2003.03057.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,1]]}},"alternative-id":["10.1046\/j.1464-410X.2003.03057.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1464-410x.2003.03057.x","archive":["Portico"],"relation":{},"ISSN":["1464-4096","1464-410X"],"issn-type":[{"type":"print","value":"1464-4096"},{"type":"electronic","value":"1464-410X"}],"subject":[],"published":{"date-parts":[[2003,1]]},"assertion":[{"value":"2003-01-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}